• HOME
• ABOUT US
  • Company Profile
  • CRO's & Pharmaceutical Companies
• COMPANY BIOS
  • Jeff Stein
  • David M. Radin, MD
  • Judith Dalgin
  • Svetlana Konnov, LPN
  • Betsy Kempner, RN
  • Patrick Brew, MD, RN
  • Tulie Brew, MD
  • Anju Sherstha, MD
• CURRENT TRIALS
  • Chronic Lower Back Pain
  • Chronic Pain
  • Interstitial Cystitis / Painful Bladder Syndrome
  • Osteoarthritis
• CONDITIONS
• CONTACT US

Alzheimer’s Disease

Alzheimer’s Disease, also known as Senile Dementia of the Alzheimer Type (SDAT), is a degenerative disease that is the most common form of dementia. Although often diagnosed in people over 65 years old, early-onset Alzheimer’s can occur in younger patients. A diagnosis may be made through a series of behavioral assessments, cognitive tests and brain scans.

Possible symptoms of Alzheimer’s Disease may include:

• Aggression
• Confusion
• Gradual Loss of Bodily Functions
• Irritability
• Language Breakdown
• Memory Loss
• Mood Swings
• Withdrawal

Sorry, Stamford Therapeutics Consortium is not currently conducting a study in this category. Please check back, as we are adding new studies all the time. You can also feel free to contact Judy Dalgin our Site Manager for more information about upcoming trials.

Judy Dalgin (Site Manager)
email: jdalgin@stctrials.com
telephone: 203-325-8529